Description of Blood Creatinine Levels in Coronary Heart Patients Based on Gender Jaffe Reaction Method at H. A Sulthan Daeng Radja Regional Hospital, Kab. Bulukumba

Authors

  • Lely Nurfadilah D3 Health Analyst Study Program, Panrita Husada Bulukumba College of Health Sciences
  • Dzikra Arwie D3 Health Analyst Study Program, Panrita Husada Bulukumba College of Health Sciences
  • Muriyati D3 Health Analyst Study Program, Panrita Husada Bulukumba College of Health Sciences

DOI:

https://doi.org/10.35706/pc.v5i1.11000

Abstract

Background: Coronary0heart0disease is a condition in which the arteries experience narrowing due to the accumulation of fat on the artery walls. Creatinine is the end product of creatinine metabolism. High or low blood creatinine levels are used0as0an important0indicator to find out whether0a person0has impaired-kidney function, because blood creatinine examination can be used as an indicator of the development of coronary heart disease which can cause kidney failure in a person. The Jaffe Reaction is the reaction between creatinine and picric acid in alkaline conditions to form an orange yellow compound which is measured using a spectrophotometer. Aim: To determine the description of blood creatinine0levels in0patients with0coronary0heart0disease based on the gender of the jaffe reaction method at H. A Sulthan0Daeng Radja0Hospital, Kab.0Bulukumba. Method: This research is a quantitative research with a cross-sectional descriptive design. The sample of this study were coronary heart patients at H. A Sulthan Daeng Radja Hospital, Kab. Bulukumba in August 2022, with a total of 42 sufferers. Result: The results obtained from 42 samples of blood creatinine levels increased in coronary heart disease patients, 7 men (54%) and 6 women (46%) with a total increase of 13 people. While normal creatinine levels in coronary heart patients were 16 men (55%) and 13 women (45%) with a normal total of 29 people. Conclusion: Based on the sex characteristics of coronary heart patients, it is known that out of a total of 42, 22 people were male, and 20 were female. Meanwhile, based on the age characteristics of the research subjects, there were 10 young people aged 35-50, 19 people 51-65, 11 people aged 66-75, 76-85 2 people. Based on examination of blood creatinine levels of 42 patients with coronary heart disease, there were 13 people who had increased blood creatinine levels, where a higher increase occurred in men, 7 people had blood creatinine levels (> 0.7-1.3 mg/dl). Meanwhile, 6 women had increased blood creatinine levels (>0.6-1.1 mg/dl).

Keywords:  Coronary heart disease, blood creatinine levels

Downloads

Download data is not yet available.

References

Nadianto F. Hubungan Penggunaan Kontrasepsi Oral Dengan Kejadian Penyakit Jantung Koroner Di Poli Jantung RSUD Hardjono Ponorogo. Occup Med (Chic Ill). 2018;53(4):130.

Suciana, Hengky HK, Usman. Analisis Faktor Risiko Penyakit Jantung Korener Pada Penderita Diabetes Melitus Tipe 2 Di RSUD Andi Makkasau Kota Parepare. Jurnal Ilmiah Manusia dan Kesehatan. 2021;4(2):254–65.

Reaginta T. Karya Tulis Ilmiah Pemeriksaan Kadar Kreatinin Pada Penderita Jantung Koroner Yang Berobat Di Rumah Sakit Umum Pusat Haji Adam Malik Medan. 2019;

Ardiansyah D, Farizal J, Irnameria D. Gambaran Kadar Kreatinin Darah Pada Pasien Penyakit Jantung Koroner Di Ruang Iccu Rsud Dr. M.Yunus Provinsi Bengkulu. Journal of Nursing and Public Health. 2018;6(2):14–8.

Loho IKA, Rambert GI, Wowor MF. Gambaran kadar ureum pada pasien penyakit ginjal kronik stadium 5 non dialisis. Jurnal e-Biomedik. 2016;4(2):2–7.

Nuratmini PN. Gambaran Kadar Ureum Dan Kreatinin Serum Pada Pasien Ggk Setelah Terapi Hemodialisis Di Rsd Mangusada, Kabupaten Badung. Vol. 53, Journal of Chemical Information and Modeling. 2019. 1689–1699 p.

Downloads

Published

2024-03-28

How to Cite

1.
Nurfadilah L, Arwie D, Muriyati M. Description of Blood Creatinine Levels in Coronary Heart Patients Based on Gender Jaffe Reaction Method at H. A Sulthan Daeng Radja Regional Hospital, Kab. Bulukumba. PharmaCine [Internet]. 2024 Mar. 28 [cited 2025 Dec. 5];5(1):13-20. Available from: https://journal.unsika.ac.id/index.php/pharmac/article/view/11000

Issue

Vol. 5 No. 1 (2024): PharmaCine: Journal of Pharmacy, Medical and Health Science

Section

Original Article

License

Copyright (c) 2024 PharmaCine : Journal of Pharmacy, Medical and Health Science

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish in PharmaCine: Journal of Pharmacy, Medical and Health Science agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

PharmaCine : Journal of Pharmacy, Medical and Health Science by https://journal.unsika.ac.id/ is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

You are free to:

  1. Share, copy and redistribute the material in any medium or format
  2. Adapt, remix, transform, and build upon the material for any purpose, even commercially.
  3. The licensor cannot revoke these freedoms as long as you follow the license terms.